The pharmaceutical sector is at a critical juncture, facing immense pressure to enhance quality management systems and ensure the safety of medications
With increasing scrutiny from regulatory bodies and a rising tide of product recalls, companies must choose between two approaches: the carrot, which symbolises incentives for quality improvement, and the stick, representing punitive measures for non-compliance. NSF experts look at the historical context, current challenges, and potential pathways for the pharma biotech sector to prioritise quality, ultimately benefiting both businesses and consumers.
